Published in Brain on November 01, 2006
Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat Rev Neurol (2010) 6.55
Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature (2009) 4.43
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psychiatry (2010) 3.64
Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med (2012) 2.36
Plasma proteins predict conversion to dementia from prodromal disease. Alzheimers Dement (2014) 1.85
Proteome-based plasma markers of brain amyloid-β deposition in non-demented older individuals. J Alzheimers Dis (2010) 1.73
Plasma biomarkers associated with the apolipoprotein E genotype and Alzheimer disease. Arch Neurol (2012) 1.66
Multivariate protein signatures of pre-clinical Alzheimer's disease in the Alzheimer's disease neuroimaging initiative (ADNI) plasma proteome dataset. PLoS One (2012) 1.51
A specific enzyme-linked immunosorbent assay for measuring beta-amyloid protein oligomers in human plasma and brain tissue of patients with Alzheimer disease. Arch Neurol (2009) 1.44
Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry (2016) 1.40
Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.38
Biomarkers of Alzheimer's disease. Neurobiol Dis (2008) 1.37
Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease. PLoS One (2011) 1.32
Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. J Lipid Res (2011) 1.24
U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease. Proc Natl Acad Sci U S A (2013) 1.23
The future of blood-based biomarkers for Alzheimer's disease. Alzheimers Dement (2013) 1.22
Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clin Exp Immunol (2008) 1.17
Blood-based biomarkers of Alzheimer's disease: challenging but feasible. Biomark Med (2010) 1.12
Proteome-based identification of plasma proteins associated with hippocampal metabolism in early Alzheimer's disease. J Neurol (2008) 1.11
Plasma biomarkers of brain atrophy in Alzheimer's disease. PLoS One (2011) 1.06
At the interface of sensory and motor dysfunctions and Alzheimer's disease. Alzheimers Dement (2014) 1.02
Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol Dis (2008) 1.01
Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease. Biochim Biophys Acta (2008) 1.01
Plasma based markers of [11C] PiB-PET brain amyloid burden. PLoS One (2012) 0.98
Do serum biomarkers really measure breast cancer? BMC Cancer (2009) 0.95
A key role for an impaired detoxification mechanism in the etiology and severity of autism spectrum disorders. Behav Brain Funct (2014) 0.95
Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study. PLoS One (2012) 0.95
CSF Biomarkers for Alzheimer's Disease Diagnosis. Int J Alzheimers Dis (2010) 0.94
The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J Alzheimers Dis (2010) 0.92
Association of social and cognitive impairment and biomarkers in autism spectrum disorders. J Neuroinflammation (2014) 0.90
'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function. J Neural Transm (Vienna) (2007) 0.89
Biomarkers of inflammation and amyloid-beta phagocytosis in patients at risk of Alzheimer disease. Exp Gerontol (2009) 0.89
Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net. Multimodal Brain Image Anal (2011) (2011) 0.89
Peripheral blood mononuclear cells as a laboratory to study dementia in the elderly. Biomed Res Int (2014) 0.87
Protein Bioinformatics Infrastructure for the Integration and Analysis of Multiple High-Throughput "omics" Data. Adv Bioinformatics (2010) 0.87
Plasma signaling proteins in persons at genetic risk for Alzheimer disease: influence of APOE genotype. Arch Neurol (2012) 0.87
Application of "omics" to prion biomarker discovery. J Biomed Biotechnol (2010) 0.86
Plasma alkaline phosphatase is elevated in Alzheimer's disease and inversely correlates with cognitive function. Int J Mol Epidemiol Genet (2011) 0.85
Plasma proteomics for the identification of Alzheimer disease. Alzheimer Dis Assoc Disord (2013) 0.85
Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer's and Parkinson's Disease. Int J Mol Sci (2016) 0.84
Microfluidic enrichment of small proteins from complex biological mixture on nanoporous silica chip. Biomicrofluidics (2011) 0.84
Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics. Proteome Sci (2014) 0.83
Biomarkers for early diagnosis of Alzheimer disease: 'ALZheimer ASsociated gene'--a new blood biomarker? J Cell Mol Med (2008) 0.82
Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders. Ann Indian Acad Neurol (2009) 0.82
Blood-Based Proteomic Biomarkers of Alzheimer's Disease Pathology. Front Neurol (2015) 0.81
Biomarkers for prediction and targeted prevention of Alzheimer's and Parkinson's diseases: evaluation of drug clinical efficacy. EPMA J (2010) 0.81
Alzheimer's Disease, Diagnosis and the Need for Biomarkers. Biomark Insights (2008) 0.81
Alterations in the red blood cell membrane proteome in alzheimer's subjects reflect disease-related changes and provide insight into altered cell morphology. Proteome Sci (2010) 0.81
Cerebrospinal fluid and blood biomarkers in Alzheimer's disease. World J Psychiatry (2011) 0.81
Multidimensional plasma protein separation technique for identification of potential Alzheimer's disease plasma biomarkers: a pilot study. J Neural Transm (Vienna) (2012) 0.80
Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics. Int J Mol Sci (2014) 0.80
Soluble interleukin-6 receptor levels and risk of dementia: one more signpost on a long road ahead. J Am Geriatr Soc (2014) 0.79
CFH Variants Affect Structural and Functional Brain Changes and Genetic Risk of Alzheimer's Disease. Neuropsychopharmacology (2015) 0.79
Deletion of Crry, the murine ortholog of the sporadic Alzheimer's disease risk gene CR1, impacts tau phosphorylation and brain CFH. Neurosci Lett (2012) 0.78
Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma. PLoS One (2015) 0.78
Potential peripheral biomarkers for the diagnosis of Alzheimer's disease. Int J Alzheimers Dis (2011) 0.78
Circulating biomarkers that predict incident dementia. Alzheimers Res Ther (2014) 0.77
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease. Croat Med J (2014) 0.77
Serum-based protein profiles of Alzheimer's disease and mild cognitive impairment in elderly Hispanics. Neurodegener Dis Manag (2016) 0.77
Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: The case of apolipoprotein A-1 proteoforms. PLoS One (2017) 0.77
SpotLight Proteomics: uncovering the hidden blood proteome improves diagnostic power of proteomics. Sci Rep (2017) 0.76
The amyloid interactome: Exploring protein aggregation. PLoS One (2017) 0.75
Apolipoprotein E isotype-dependent modulation of microRNA-146a in plasma and brain. Neuroreport (2016) 0.75
Multiplex biomarkers in blood. Alzheimers Res Ther (2013) 0.75
Low oxytocin and melatonin levels and their possible role in the diagnosis and prognosis in Iraqi autistic children. Saudi Med J (2016) 0.75
Modulation of miR-146a/ complement factor H mediated inflammatory responses in a rat model of temporal lobe epilepsy. Biosci Rep (2016) 0.75
A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis. J Alzheimers Dis (2015) 0.75
Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study. J Alzheimers Dis (2012) 0.75
Teaming up for biomarker future. Many problems still hinder the use of biomarkers in clinical practice, but new public-private partnerships could improve the situation. EMBO Rep (2011) 0.75
Estimation of Tau and Phosphorylated Tau181 in Serum of Alzheimer's Disease and Mild Cognitive Impairment Patients. PLoS One (2016) 0.75
Alzheimer's disease: are blood and brain markers related? A systematic review. Ann Clin Transl Neurol (2016) 0.75
Association of cerebrospinal fluid Aβ42 with A2M gene in cognitively normal subjects. Neurobiol Aging (2013) 0.75
A semi-mechanism approach based on MRI and proteomics for prediction of conversion from mild cognitive impairment to Alzheimer's disease. Sci Rep (2016) 0.75
Influence of CFH gene on symptom severity of schizophrenia. Neuropsychiatr Dis Treat (2017) 0.75
A survey of membrane proteins in human serum. Proteomics Insights (2012) 0.75
Alzheimer's Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid. Front Neurol (2017) 0.75
Alzheimer's disease biomarkers in animal models: closing the translational gap. Am J Neurodegener Dis (2013) 0.75
Differential diagnosis of Alzheimer's disease using spectrochemical analysis of blood. Proc Natl Acad Sci U S A (2017) 0.75
Plasma Levels of Aβ42 and Tau Identified Probable Alzheimer's Dementia: Findings in Two Cohorts. Front Aging Neurosci (2017) 0.75
Study on Analysis of Peripheral Biomarkers for Alzheimer's Disease Diagnosis. Front Neurol (2017) 0.75
Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol (1988) 35.68
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology (1996) 12.33
dbSNP-database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res (1999) 11.40
Stromal gene signatures in large-B-cell lymphomas. N Engl J Med (2008) 11.34
Assembly of microarrays for genome-wide measurement of DNA copy number. Nat Genet (2001) 11.06
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
The Mouse Genome Database (MGD): integrating biology with the genome. Nucleic Acids Res (2004) 8.91
The Mouse Genome Database (MGD): from genes to mice--a community resource for mouse biology. Nucleic Acids Res (2005) 8.19
dbSNP: a database of single nucleotide polymorphisms. Nucleic Acids Res (2000) 6.84
Anterior pituitary extracts and liver fat. J Physiol (1936) 5.94
The intersections of HIV and violence: directions for future research and interventions. Soc Sci Med (2000) 5.78
Providing census data for general practice. 2. Usefulness. J R Coll Gen Pract (1987) 5.24
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med (2001) 4.83
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group. N Engl J Med (1996) 4.43
Comparison of two scores for allocating resources to doctors in deprived areas. BMJ (1989) 4.21
Providing census data for general practice. 1. Feasibility. J R Coll Gen Pract (1987) 4.10
Evaluation of the necessity for routine terminal subcultures of previously negative blood cultures. J Clin Microbiol (1980) 4.08
Measuring physical impairment and disability with the Chedoke-McMaster Stroke Assessment. Stroke (1993) 3.90
Head injury as a risk factor for Alzheimer's disease: the evidence 10 years on; a partial replication. J Neurol Neurosurg Psychiatry (2003) 3.87
Production of diagnostic pigment by phenoloxidase activity of cryptococcus neoformans. Appl Microbiol (1972) 3.86
Phytochrome regulation and differential expression of gibberellin 3beta-hydroxylase genes in germinating Arabidopsis seeds. Plant Cell (1998) 3.76
Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 3.65
Gene-environment interaction analysis of serotonin system markers with adolescent depression. Mol Psychiatry (2004) 3.54
The effect of anterior pituitary extracts on the insulin content of the pancreas. J Physiol (1939) 3.54
Spiral Tube Assembly for High-Speed Countercurrent Chromatography: Choice of Elution Modes for Four Typical Two-Phase Solvent Systems. J Liq Chromatogr Relat Technol (2008) 3.33
Statistical methods of estimation and inference for functional MR image analysis. Magn Reson Med (1996) 3.13
Pharmacogenetic prediction of clozapine response. Lancet (2000) 3.10
Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis. Eur Heart J (2002) 3.09
The role of cutaneous diphtheria infections in a diphtheria epidemic. J Infect Dis (1975) 3.08
Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet (1995) 3.08
Complete genome sequence of Vibrio fischeri: a symbiotic bacterium with pathogenic congeners. Proc Natl Acad Sci U S A (2005) 3.05
Clostridium difficile toxin B is more potent than toxin A in damaging human colonic epithelium in vitro. J Clin Invest (1995) 2.91
A new model of diffuse brain injury in rats. Part I: Pathophysiology and biomechanics. J Neurosurg (1994) 2.90
Acute compartment syndromes. Br J Surg (2002) 2.81
Fixation of fractures of the shaft of the humerus by dynamic compression plate or intramedullary nail. A prospective, randomised trial. J Bone Joint Surg Br (2000) 2.81
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet (1991) 2.74
The assessment of fatigue: a practical guide for clinicians and researchers. J Psychosom Res (2004) 2.72
Behavioral engineering: the reduction of smoking behavior by a conditioning apparatus and procedure. J Appl Behav Anal (1968) 2.71
DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet (1997) 2.64
A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry (1996) 2.60
Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev (2006) 2.59
The anatomy of melancholia--focal abnormalities of cerebral blood flow in major depression. Psychol Med (1992) 2.58
Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. BMJ (2000) 2.56
Prozone phenomenon in secondary syphilis. Has its time arrived? Arch Intern Med (1993) 2.55
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis (2010) 2.52
Susceptibility locus for Alzheimer's disease on chromosome 10. Science (2000) 2.49
Randomized trial of intake of fat, fiber, and beta carotene to prevent colorectal adenomas. J Natl Cancer Inst (1995) 2.49
A SNP resource for human chromosome 22: extracting dense clusters of SNPs from the genomic sequence. Genome Res (2001) 2.49
Improved spiral tube assembly for high-speed counter-current chromatography. J Chromatogr A (2008) 2.48
The effect of insulin and anterior pituitary extract on the insulin content of the pancreas and the histology of the islets. J Physiol (1942) 2.48
Persistent hepatitis and enterocolitis in germfree mice infected with Helicobacter hepaticus. Infect Immun (1996) 2.47
Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect Immun (1997) 2.46
An interpretation of the modern rise of population in Europe. Popul Stud (Camb) (1972) 2.45
Cancer-associated hypercalcemia: morbidity and mortality. Clinical experience in 126 treated patients. Ann Intern Med (1990) 2.43
The pathogenesis of Crohn's disease. Lancet (1977) 2.37
'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain (1988) 2.36
Safety and biological efficacy of a lipid-CFTR complex for gene transfer in the nasal epithelium of adult patients with cystic fibrosis. Mol Ther (2000) 2.34
Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study. Neurobiol Dis (2004) 2.29
Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry (1998) 2.28
A full genome scan for late onset Alzheimer's disease. Hum Mol Genet (1999) 2.26
Importance of both folic acid and vitamin B12 in reduction of risk of vascular disease. Lancet (2002) 2.25
The primate lentiviral receptor Bonzo/STRL33 is coordinately regulated with CCR5 and its expression pattern is conserved between human and mouse. J Immunol (2000) 2.22
SSB-1 of the yeast Saccharomyces cerevisiae is a nucleolar-specific, silver-binding protein that is associated with the snR10 and snR11 small nuclear RNAs. J Cell Biol (1990) 2.21
Temporal constraints on the McGurk effect. Percept Psychophys (1996) 2.19
Payment to healthcare professionals for patient recruitment to trials: a systematic review. BMJ (2005) 2.16
An estimate of amyotrophic lateral sclerosis heritability using twin data. J Neurol Neurosurg Psychiatry (2010) 2.14
Genetic resource impacts of habitat loss and degradation; reconciling empirical evidence and predicted theory for neotropical trees. Heredity (Edinb) (2005) 2.11
Hospitalist concept: another dangerous trend. Am Fam Physician (1998) 2.11
The sand seas of Titan: Cassini RADAR observations of longitudinal dunes. Science (2006) 2.11
Clinicopathological staging of gastric cancer. Br J Surg (1984) 2.10
Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med (2000) 2.09
Countercurrent immunoelectrophoresis in the evaluation of childhood infections. J Pediatr (1974) 2.06
Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04
Hypocalcaemia and vitamin D deficiency: an important, but preventable, cause of life-threatening infant heart failure. Heart (2007) 2.04
The Department of Military Medicine--a graduate medical education idea whose time has come. Mil Med (1989) 2.04
Predicting outcome in anaesthesia: understanding statistical methods. Anaesth Intensive Care (1994) 2.03
Behavioral engineering: the use of response priming to improve prescribed self-medication. J Appl Behav Anal (1969) 2.02
Provision of vascular surgery in England in 2012. Eur J Vasc Endovasc Surg (2012) 2.02
Psychopathological syndromes and familial morbid risk of psychosis. Br J Psychiatry (1997) 2.02
Genetic contributions to regional variability in human brain structure: methods and preliminary results. Neuroimage (2002) 2.01
Hepatic triglyceride content and its relation to body adiposity: a magnetic resonance imaging and proton magnetic resonance spectroscopy study. Gut (2005) 1.99
The lakes of Titan. Nature (2007) 1.97
Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium. Am J Hum Genet (1992) 1.94
How common is dementia in Parkinson's disease? Lancet (1984) 1.93
Rabbit antibodies to histone fractions as specific reagents for preparative and comparative studies. J Biol Chem (1970) 1.93
Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjögren's syndrome. Ann Neurol (1990) 1.92
Improving nurse retention in the National Health Service in England: the impact of job satisfaction on intentions to quit. J Health Econ (2001) 1.92
Understanding ethnic and other socio-demographic differences in patient experience of primary care: evidence from the English General Practice Patient Survey. BMJ Qual Saf (2011) 1.92
Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J (1999) 1.87
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: a randomised, controlled trial. Cancer Chemother Pharmacol (1986) 1.87
How accurate is self-reported family history of colorectal cancer? Am J Epidemiol (1995) 1.86
The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am (1989) 1.86
A genome-wide scan of 1842 DNA markers for allelic associations with general cognitive ability: a five-stage design using DNA pooling and extreme selected groups. Behav Genet (2001) 1.86
A decision support system for prevention and treatment of pressure ulcers based on AHCPR guidelines. Proc AMIA Annu Fall Symp (1996) 1.83
Prenatal diagnosis of coarctation of the aorta improves survival and reduces morbidity. Heart (2002) 1.83
Psychological factors in breast cancer. BMJ (1991) 1.82